Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px download

News > All

Find below news from the Portugal and Spain. Listed are news about these countries as well as from organisations located there.

Total search results: 306 | Ordered by Date (descending)
1 2 3 4  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
[iito] Business Intelligence. (–). "THIS IS A BETA VERSION! NOT INTENDED FOR PUBLIC USE! The official launch of Life-Sciences-Spain.com will be announced in due time by [iito] Business Intelligence". 2020-01-01
[iito] Business Intelligence. (–). "THIS IS A BETA VERSION! NOT INTENDED FOR PUBLIC USE! The official launch of Life-Sciences-Spain.com will be announced in due time by [iito] Business Intelligence". 2020-01-01
[iito] Business Intelligence. (–). "THIS IS A BETA VERSION! NOT INTENDED FOR PUBLIC USE! The official launch of Life-Sciences-Spain.com will be announced in due time by [iito] Business Intelligence". 2020-01-01
Roche. (9/8/17). "Press Release: Roche Announces Progress in Biomarker Science in Cancer Immunotherapy at the European Society for Medical Oncology Congress". Basel. 2017-09-08
Merck KGaA. (8/31/17). "Press Release: Driving Innovation in Cancer Care at ESMO 2017 with New Data in Hard-to-Treat Cancers [Not intended for U.K. or U.S. based media]". Darmstadt. 2017-08-31
Thermo Fisher Scientific Inc.. (8/29/17). "Press Release: Thermo Fisher Scientific Completes Acquisition of Patheon". Waltham, MA. 2017-08-29
Almirall S.A.. (8/28/17). "Press Release: Almirall Appoints Peter Guenter as New CEO". Barcelona. 2017-08-28
Amcure GmbH. (8/23/17). "Press Release: Amcure Announces Formation of Inaugural Scientific Advisory Board". Eggenstein-Leopoldshafen. 2017-08-23
SpectralWorks Ltd.. (8/15/17). "Press Release: SpectralWorks and Mestrelab Research SL Announce Mutual Reseller Agreement". 2017-08-15
Sygnis AG. (8/3/17). "Press Release: Sygnis AG Reports Financial Results for the Second Quarter and First Six Months of 2017". Madrid & Heidelberg. 2017-08-03
Grifols S.A.. (7/28/17). "Press Release: Grifols Increases Its Revenues by 12.3% to EUR 2,192 Million Driven by Growth of Its Main Divisions". Barcelona. 2017-07-28
AB Sciex (d/b/a Sciex). (7/27/17). "Press Release: Sciex Equipment Is Now Available Through a Wide Range of Flexible Financing Packages via Evosciences". Warrington. 2017-07-27
Oryzon Genomics S.A.. (7/20/17). "Press Release: Oryzon to Regain Rights to ORY-1001 (RG6016)". Barcelona & Cambridge, MA. 2017-07-20
Grifols S.A.. (7/5/17). "Press Release: Grifols Strengthens Its R&D+i through Investee Companies. Grifols Opens New Lines of Research with the Acquisition of a 44% Stake in GigaGen for USD 35 Million". Barcelona. 2017-07-05
Cellnovo. (6/29/17). "Press Release: Cellnovo Expands International Distribution Network". Paris. 2017-06-29
Invent Farma Holding Spain S.L.. (6/21/17). "Press Release: Invent Farma / Neuraxpharm Group Announces the Acquisition of FB Health in Italy". Barcelona & Düsseldorf. 2017-06-21
OBN (UK) Ltd.. (6/20/17). "Press Release: OBN (UK) and Eurasanté (FR) Announce the Launch of BioSeed. A New European Equity Investment Event to Support Early-Stage Companies in Life Sciences". Oxford. 2017-06-20
Sygnis AG. (6/6/17). "Press Release: Sygnis AG Announces Management and Supervisory Board Changes. Dr. Heikki Lanckriet Sole CEO". Madrid & Heidelberg. 2017-06-06
AB Sciex (d/b/a Sciex). (6/1/17). "Press Release: Sciex Launches Its Unrivalled Swath Data Independent Acquisition Technology for Comprehensive Analysis of Food, Forensic and Environmental Samples". Framingham, MA. 2017-06-01
Oryzon Genomics S.A.. (5/31/17). "Press Release: Oryzon Genomics to Participate in a Panel at the JMP Securities Life Sciences Conference and Present at the Jefferies 2017 Global Health Conference". Barcelona & Cambridge, MA. 2017-05-31
PharmaMar S.A.. (5/18/17). "Press Release: PharmaMar Announces New Data with Its Compounds Yondelis and Lurbinectedin during ASCO 2017". Madrid. 2017-05-18
AptaTargets. (5/17/17). "Press Release: AptaTargets Closes €2.7 Million Round of Funding for New Stroke Treatment". Madrid. 2017-05-17
Cinfa Biotech S.L.. (5/17/17). "Press Release: Cinfa Biotech Announces Positive Top-line Data from Second Clinical Study with Pegfilgrastim Biosimilar Candidate B12019". Pamplona. 2017-05-17
PharmaMar S.A.. (5/17/17). "Press Release: PharmaMar and Specialised Therapeutics Asia Sign Licensing and Marketing Agreement for Lurbinectedin Covering Australia, New Zealand and Several Asian Countries". Madrid. 2017-05-17
Oryzon Genomics S.A.. (5/16/17). "Press Release: Oryzon Announces Appointment of New Chief Medical Officer and Expansion of Its Medical Department". Barcelona & Cambridge, MA. 2017-05-16
Celyad S.A.. (5/11/17). "Press Release: FDA Grants Fast Track Designation for Celyad’s Ischemic Heart Failure Therapy, C-Cure". Mont-Saint-Guibert. 2017-05-11
ThromboGenics N.V.. (5/11/17). "Press Release: ThromboGenics Business Update – Q1 2017. Progressing Innovative Diabetic Eye Disease Clinical and Pre-Clinical Portfolio". Leuven. 2017-05-11
Sygnis AG. (5/8/17). "Press Release: Sygnis AG Plans to Acquire Profitable Innova Biosciences Ltd. for EUR 8 Million in Cash and up to 3.5 Million Shares [Not for USA, Canada, Japan and Australia]". Madrid & Heidelberg. 2017-05-08
PharmaMar S.A.. (5/4/17). "Press Release: Aplidin Receives Orphan Drug Status for the Treatment of Multiple Myeloma in Switzerland". Madrid. 2017-05-04
Vivet Therapeutics S.A.S.. (5/4/17). "Press Release: Vivet Therapeutics Raises €37.5 Million in Series A Financing Round to Advance Novel Gene Therapies for Treating Inherited Metabolic Diseases". Paris. 2017-05-04
Celyad S.A.. (5/3/17). "Press Release: Celyad to Present at the Deutsche Bank 42nd Annual Health Care Conference". Mont-Saint-Guibert. 2017-05-03
Abivax S.A.. (5/2/17). "Press Release: First Ever Evidence of Treatment-induced Reduction in HIV Reservoirs". Paris. 2017-05-02
Celyad S.A.. (5/2/17). "Press Release: Celyad Grants to Novartis a Non-exclusive License for Its Allogeneic TCR-deficient CAR-T Cells Patents". Mont-Saint-Guibert. 2017-05-02
Medigene AG. (4/28/17). "Press Release: Medigene Announces Participation at Six International Conferences". Planegg. 2017-04-28
Sygnis AG. (4/27/17). "Press Release: Sygnis AG Reports Financial Results for Fiscal Year 2016". Madrid & Heidelberg. 2017-04-27
Enamine Ltd.. (4/25/17). "Press Release: Enamine to Collaborate with EMBL for Cancer Drug Discovery Research". Kiev. 2017-04-25
Sygnis AG. (4/24/17). "Press Release: Sygnis AG Expands Access to Chinese Market with Second OEM Deal with Tanon". Madrid & Heidelberg. 2017-04-24
Sygnis AG. (4/11/17). "Press Release: Sygnis AG Successfully Completes Integration of Recently Acquired C.B.S. Scientific". Madrid & Heidelberg. 2017-04-11
Oryzon Genomics S.A.. (3/31/17). "Press Release: Oryzon Raises €18 Million through a Private Placement with US and European Investors [Not for US, CA, AU, JP, ZA, et al.]". Barcelona. 2017-03-31
AB Science S.A.. (3/31/17). "Press Release: AB Science Announces the Success of a Private Placement [Not for US, CA or JP]". Paris. 2017-03-31
Neovacs S.A.. (3/30/17). "Press Release: Neovacs Provides Corporate Update and Reports Full Year 2016 Financial Results". Paris. 2017-03-30
Versantis AG. (3/29/17). "Press Release: Versantis Raises CHF 4.4 Million in Series A Financing to Advance New Generation of Liver Disease Medicines". Zurich. 2017-03-29
Medigene AG. (3/28/17). "Press Release: Medigene Announces Participation at Six National and International Conferences". Planegg. 2017-03-28
AB Science S.A.. (3/27/17). "Press Release: AB Science Announces the Success of a Private Placement [Not for US, CA or JP]". Paris. 2017-03-27
BioClin Therapeutics, Inc.. (3/22/17). "Press Release: BioClin Therapeutics, Inc., Raises $30 Million in Series B Financing Led by Sofinnova Ventures and Ysios Capital". San Ramon, CA. 2017-03-22
Medivir AB. (3/16/17). "Press Release: Medivir Completes Transition of Commercial Products to Fully Focus on Research and Development". Stockholm. 2017-03-16
Alimera Sciences, Inc.. (3/13/17). "Press Release: Alimera Sciences Signs Agreement for Exclusive Distributor of Iluvien in Spain". Atlanta, GA. 2017-03-13
Newron Pharmaceuticals S.p.A.. (3/2/17). "Press Release: Newron Announces 2016 Financial Results and Provides Outlook for 2017". Milan. 2017-03-02
Eurofins Scientific. (2/28/17). "Press Release: Eurofins Achieves Its Recently-upgraded 2016 Objectives and Delivers Its Best Year Ever on Sustained Growth Momentum". 2017-02-28
EFPIA. (2/22/17). "Press Release: Nathalie Moll Announced as New EFPIA Director General, Starting in April 2017". 2017-02-22
Minoryx Therapeutics S.L.. (2/22/17). "Press Release: Minoryx Therapeutics Receives Orphan Drug Designation from the US FDA for Its Lead Candidate MIN-102". Mataró, Barcelona. 2017-02-22
mAbxience S.L.. (2/13/17). "Press Release: mAbxience, European Success Accelerating Global Growth". 2017-02-13
Minoryx Therapeutics S.L.. (2/8/17). "Press Release: Dr Claude Nicaise Joins Minoryx Therapeutics as Independent Board Member". Mataró, Barcelona. 2017-02-08
Forbion Capital Partners. (2/7/17). "Press Release: Forbion Invests in Prexton Therapeutics’ EUR 29 Million (USD 31 Million) Series B Financing". Naarden. 2017-02-07
Medigene AG. (2/2/17). "Press Release: Medigene Participates at Five National and International Conferences in February and March 2017". Martinsried. 2017-02-02
Sygnis AG. (2/2/17). "Press Release: Sygnis AG Announces the Launch of TrueHelix". Madrid & Heidelberg. 2017-02-02
Iproteos S.L.. (1/26/17). "Press Release: Grant of 700,000 € for the Discovery of Drugs against Atherosclerosis". 2017-01-26
Minoryx Therapeutics S.L.. (1/18/17). "Press Release: Minoryx Therapeutics Further Strengthens Its Scientific Advisory Board (SAB)". Mataró, Barcelona. 2017-01-18
Eurofins Scientific. (12/29/16). "Press Release: Eurofins Reinforces Its Footprint in Discovery Pharmacology with the Acquisition of Villapharma in Spain". 2016-12-29
Sygnis AG. (12/21/16). "Press Release: Sygnis AG Acquires Profitable US Life Sciences Tools Company C.B.S. Scientific for US $0.9 Million in Cash and Shares". Madrid & Heidelberg. 2016-12-21
TiGenix N.V.. (12/15/16). "Press Release: TiGenix Raises $35.65 Million Gross Proceeds with NASDAQ IPO". Leuven. 2016-12-15
Minoryx Therapeutics S.L.. (12/14/16). "Press Release: Minoryx Therapeutics Receives European Orphan Drug Designation for Its Lead Candidate MIN-102". Mataró, Barcelona. 2016-12-14
Grifols S.A.. (12/14/16). "Press Release: Grifols Agrees to Acquire Hologic's Share of NAT Donor Screening Unit for USD 1,850 Million". Barcelona. 2016-12-14
MolMed S.p.A.. (12/12/16). "Press Release: MolMed Coordinates a CAR T-cell Immunotherapy Project Awarded a 5.9 million Euro Grant by the European Commission". Milan. 2016-12-12
SGS S.A.. (12/9/16). "Press Release: SGS Acquires 70 Percent Stake in Biopremier, Portugal". 2016-12-09
PharmaMar S.A.. (12/1/16). "Press Release: PharmaMar Presents Positive Results with Its Conjugated Antibody MI130110 in CD13-expressing Tumor-cells". Madrid. 2016-12-01
OxThera AB. (11/29/16). "Press Release: OxThera Raises EUR 32 Million to Complete Development of Oxabact for Treatment of Primary Hyperoxaluria". Stockholm. 2016-11-29
PharmaMar S.A.. (11/28/16). "Press Release: PharmaMar Begins a Phase I Study of PM1183 in Japan for the Treatment of Solid Tumors". Madrid. 2016-11-28
Sygnis AG. (11/28/16). "Press Release: Sygnis AG Reinforces Its Proteomics Portfolio with Two Patents Granted in Europe and China". Madrid & Heidelberg. 2016-11-28
Neovacs S.A.. (11/23/16). "Press Release: Neovacs Signs Production Partnership with 3P Biopharmaceuticals, a Leading GMP Producer of Biological Drugs". Paris & Boston, MA. 2016-11-23
Bruker Corporation. (11/22/16). "Press Release: Bruker Completes Acquisition of Preclinical PET Imaging Business". Billerica, MA. 2016-11-22
Ability Pharmaceuticals S.L.. (11/22/16). "Press Release: Ability Pharmaceuticals Initiates Phase 2 Combination Trial with ABTL0812 as First Line Therapy in Patients with Endometrial or Squamous Lung Cancer". Barcelona. 2016-11-22
Sygnis AG. (11/18/16). "Press Release: Sygnis AG to Present at Upcoming Investor Conferences". Madrid & Heidelberg. 2016-11-18
PharmaMar S.A.. (11/16/16). "Press Release: PharmaMar Appoints Pascal Besman as Chief Operating Officer of PharmaMar U.S.". Madrid & New York, NY. 2016-11-16
Sygnis AG. (11/16/16). "Press Release: Sygnis AG Launches TruePrime Liquid Biopsy Kit targeting Oncology Research and Diagnostics". Madrid & Heidelberg. 2016-11-16
PharmaMar S.A.. (11/10/16). "Press Release: PharmaMar Shows New Clinical Data with Yondelis in Different Sarcoma Subtypes at CTOS 2016". Madrid. 2016-11-10
Sygnis AG. (11/9/16). "Press Release: Sygnis AG Reports Nine Month Results for the Period Ended September 30, 2016". Madrid & Heidelberg. 2016-11-09
CorWave. (11/4/16). "Press Release: CorWave Raises $17.1 Million in Series B Financing". Paris. 2016-11-04
PharmaMar S.A.. (10/28/16). "Press Release: The EMA Accepts to Assess the Marketing Authorization Application from PharmaMar for Aplidin". Madrid. 2016-10-28
PharmaMar S.A.. (10/27/16). "Press Release: PharmaMar Group Reports 9M 2016 Financial Results". Madrid. 2016-10-27
Sygnis AG. (10/27/16). "Press Release: Sygnis AG to Receive €1.9 Million Non-dilutive R&D Funding from the Spanish Government". Madrid & Heidelberg. 2016-10-27
Onxeo S.A.. (10/27/16). "Press Release: Onxeo Announces Promising Results from Preclinical Study of Beleodaq Combination with Checkpoint Inhibitors". Paris & Copenhagen. 2016-10-27
OncoDNA S.A.. (10/26/16). "Press Release: OncoDNA Signs Agreement with SOLTI to Provide Tumor Molecular Profile Analysis to Breast Cancer Patients in AGATA Screening Program". Brussels & Barcelona. 2016-10-26
Iproteos S.L.. (10/25/16). "Press Release: Iproteos Closes a Round of Funding Valued at 1.5 Millon Euros". Barcelona. 2016-10-25
PharmaMar S.A.. (10/24/16). "Press Release: PharmaMar Announces the Opening of a New Affiliate in Austria". Madrid. 2016-10-24
Protagen AG. (10/18/16). "Press Release: Protagen AG Announces Changes to Their Management Board". 2016-10-18
Ysios Capital. (10/18/16). "Press Release: Ysios Capital Raises €126,4 m ($140 m) for Its Second Fund, Ysios Biofund II Innvierte". Barcelona. 2016-10-18
Selexis S.A.. (10/10/16). "Press Release: Selexis SA Announces Participation at Two Upcoming Industry Conferences". Geneva. 2016-10-10
PharmaMar S.A.. (10/4/16). "Press Release: PharmaMar and Boryung Pharm Sign a Licensing Agreement for Aplidin (plitidepsin) in Korea". Madrid. 2016-10-04
Eurofins Scientific. (9/30/16). "Press Release: Eurofins Expands Its Clinical Diagnostic Footprint with the Acquisition of Megalab in Spain". 2016-09-30
Oryzon Genomics S.A.. (9/26/16). "Press Release: Oryzon Closes € 5.3 Million (6 M USD) in Additional Debt Financing". Barcelona & Cambridge, MA. 2016-09-26
PharmaMar S.A.. (9/22/16). "Press Release: PharmaMar Submits MAA to EMA for Aplidin for the Treatment of Multiple Myeloma". Madrid. 2016-09-22
Sygnis AG. (9/22/16). "Press Release: Sygnis AG Enters into Collaboration Agreement with ECACC for Licensing and Distribution of Caco-2 Cell Line". Madrid & Heidelberg. 2016-09-22
Orchard Therapeutics Ltd.. (9/21/16). "Press Release: Orchard Therapeutics Announces Presentations from UCL/GOSH and UCLA Academic Collaborators on Clinical Data in ADA-SCID Using Ex-Vivo Lentiviral Gene Therapy at September 2016 ESID and ESGCT Congresse 2016-09-21
Merck KGaA. (9/14/16). "Press Release: Merck Joins DiViNe Consortium to Address Low Yields, High Costs of Vaccine Purification Processes". Darmstadt. 2016-09-14
Sanofi S.A.. (9/13/16). "Press Release: Sanofi’s Fixed-Ratio Combination Helps More Patients Reach Mealtime Blood Sugar Target than Insulin Glargine Alone". Paris. 2016-09-13
Bruker Corporation. (9/7/16). "Press Release: Bruker Signs Agreement to Acquire Oncovision’s Preclinical PET Imaging Business". New York, NY. 2016-09-07
Oryzon Genomics S.A.. (9/1/16). "Press Release: Oryzon Genomics to Present at the 18th Annual Rodman & Renshaw Global Investment Conference and at BioPharm America 2016". Barcelona & Cambridge, MA. 2016-09-01
Protagen AG. (8/11/16). "Press Release: Protagen Inks License Agreement with Inova Diagnostics for Its Proprietary BICD2 Biomarker". 2016-08-11
Sygnis AG. (8/8/16). "Press Release: Sygnis AG Strengthens Management Team with Appointment of Dr. Heikki Lanckriet". Madrid & Heidelberg. 2016-08-08
1 2 3 4  next pagenext page



Advertisement

Picture BIO Deutschland EBDC 2017 Heidelberg 600x60px

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px download

» top

Advertisements

Picture Berlin Partner HealthCapital BIO-Europe 2017 Germany November 120x240px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px 22 Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Save USD100 120x180px Picture Berlin Partner HealthCapital BIO-Europe 2017 Germany November 120x240px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px 41 Picture EBD Group BioPharm America 2017 BPA Boston MA Save USD100 120x180px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px